PLEKHA8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.975800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.359400E-01
Normal-vs-Stage2
7.190200E-01
Normal-vs-Stage3
2.046400E-01
Normal-vs-Stage4
4.038000E-01
Stage1-vs-Stage2
8.499600E-01
Stage1-vs-Stage3
2.322200E-01
Stage1-vs-Stage4
4.465800E-01
Stage2-vs-Stage3
1.254760E-01
Stage2-vs-Stage4
3.568200E-01
Stage3-vs-Stage4
1.071620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.844000E-01
Normal-vs-AfricanAmerican
1.724040E-01
Normal-vs-Asian
6.289400E-01
Caucasian-vs-AfricanAmerican
3.148000E-02
Caucasian-vs-Asian
2.925600E-01
AfricanAmerican-vs-Asian
4.078000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.724400E-01
Normal-vs-Female
8.207600E-01
Male-vs-Female
8.575400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.800400E-01
Normal-vs-Age(41-60Yrs)
4.931400E-01
Normal-vs-Age(61-80Yrs)
9.691600E-01
Normal-vs-Age(81-100Yrs)
8.738000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.739600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.560400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.208400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.355680E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.242560E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.951200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.962600E-01
Normal-vs-Daily Drinker
5.508600E-01
Normal-vs-Weekly Drinker
8.141600E-01
Normal-vs-Occasional Drinker
6.471400E-01
Normal-vs-Social Drinker
2.933800E-01
Non Drinker-vs-Daily Drinker
2.388600E-01
Non Drinker-vs-Weekly Drinker
6.779600E-01
Non Drinker-vs-Occasional Drinker
3.444600E-01
Non Drinker-vs-Social Drinker
6.283900E-02
Daily Drinker-vs-Weekly Drinker
1.511010E-01
Daily Drinker-vs-Occasional Drinker
5.312200E-02
Daily Drinker-vs-Social Drinker
4.257400E-03
Weekly Drinker-vs-Occasional Drinker
6.607200E-01
Weekly Drinker-vs-Social Drinker
1.955230E-01
Occasional Drinker-vs-Social Drinker
4.056200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.380980E-01
Normal-vs-Grade 2
2.346200E-02
Normal-vs-Grade 3
3.166100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.090000E-01
Grade 1-vs-Grade 3
2.681000E-01
Grade 1-vs-Grade 4
1.380980E-01
Grade 2-vs-Grade 3
9.523200E-01
Grade 2-vs-Grade 4
2.346200E-02
Grade 3-vs-Grade 4
3.166100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.242800E-01
Normal-vs-NonDiabetic
8.142200E-01
Diabetic-vs-NonDiabetic
1.286230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.821600E-01
Normal-vs-NoPancreatitis
9.396200E-01
Pancreatitis-vs-NoPancreatitis
3.931900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.340600E-01
Normal-vs-N1
7.407200E-01
N0-vs-N1
3.849400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.647200E-01
Normal-vs-TP53-NonMutant
9.144400E-01
TP53-Mutant-vs-TP53-NonMutant
5.746800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
